PubMed Health⌕ Search

PubMed · 14682929

Local density fluctuations, hyperuniformity, and order metrics.

Abstract

Questions concerning the properties and quantification of density fluctuations in point patterns continue to provide many theoretical challenges. The purpose of this paper is to characterize certain fundamental aspects of local density fluctuations associated with general point patterns in any space dimension d. Our specific objectives are to study the variance in the number of points contained within a regularly shaped window Omega of arbitrary size, and to further illuminate our understanding of hyperuniform systems, i.e., point patterns that do not possess infinite-wavelength fluctuations. For large windows, hyperuniform systems are characterized by a local variance that grows only as the surface area (rather than the volume) of the window. We derive two formulations for the number variance: (i) an ensemble-average formulation, which is valid for statistically homogeneous systems, and (ii) a volume-average formulation, applicable to a single realization of a general point pattern in the large-system limit. The ensemble-average formulation (which includes both real-space and Fourier representations) enables us to show that a homogeneous point pattern in a hyperuniform state is at a "critical point" of a type with appropriate scaling laws and critical exponents, but one in which the direct correlation function (rather than the pair correlation function) is long ranged. We also prove that the non-negativity of the local number variance does not add a new realizability condition on the pair correlation. The volume-average formulation is superior for certain computational purposes, including optimization studies in which it is desired to find the particular point pattern with an extremal or targeted value of the variance. We prove that the simple periodic linear array yields the global minimum value of the average variance among all infinite one-dimensional hyperuniform patterns. We also evaluate the variance for common infinite periodic lattices as well as certain nonperiodic point patterns in one, two, and three dimensions for spherical windows, enabling us to rank-order the spatial patterns. Our results suggest that the local variance may serve as a useful order metric for general point patterns. Contrary to the conjecture that the lattices associated with the densest packing of congruent spheres have the smallest variance regardless of the space dimension, we show that for d=3, the body-centered cubic lattice has a smaller variance than the face-centered cubic lattice. Finally, for certain hyperuniform disordered point patterns, we evaluate the direct correlation function, structure factor, and associated critical exponents exactly.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Salvatore Torquato, Frank H Stillinger. 2003-10-29. Local density fluctuations, hyperuniformity, and order metrics.. https://doi.org/10.1103/physreve.68.041113

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗